The diffusion of nandrolone through hydrated human cadaver skin

Predicting human skin absorption of chemicals: development of a novel quantitative structure activity relationship

The objective of this study was to construct and validate a quantitative structure-activity relationship model for skin absorption. Such models are valuable tools for screening and prioritization in safety and efficacy evaluation, and risk assessment of drugs and chemicals. A database of 340 chemicals with percutaneous absorption was assembled. Two models were derived from the training set consisting 306 chemicals (90/10 random split). In addition to the experimental Kow values, over 300 2D and 3D atomic and molecular descriptors were analyzed using MDL's QsarIS computer program. Subsequently, the models were validated using both internal (leave-one-out) and external validation (test set) procedures. Using the stepwise regression analysis, three molecular descriptors were determined to have significant statistical correlation with Kp (R2 = 0.8225): logKow, ×0 (quantification of both molecular size and the degree of skeletal branching), and SsssCH (count of aromatic carbon groups). In conclusion, two models to estimate skin absorption were developed. When compared to other skin absorption QSAR models in the literature, our model incorporated more chemicals and explored a large number of descriptors. Additionally, our models are reasonably predictive and have met both internal and external statistical validations. Toxicology and Industrial Health 2007; 23: 39—45.

Skin permeation: The years of enlightenment

Considerable advances in our understanding of the mechanisms by which drugs permeate the skin barrier have been made over the past 60 years. The key publications, which have influenced the field of skin permeation research are highlighted in the present review. The methodologies commonly employed for estimation of skin permeability are discussed as are the mechanisms proposed for skin permeation. The principal findings from the commonly employed in vitro and in vivo models are considered as well as the applications of enhancers and surfactants for optimization of skin delivery. As these studies presaged the emergence of transdermal drug delivery research in the 1970s, early approaches to model and predict dermal and transdermal absorption are also outlined. The published work on skin permeability in this period embodies the fundamental literature sources for consultation by scientists new to and currently engaged in transdermal drug delivery.

Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers

Previous permeant partitioning studies with hairless mouse skin (HMS) in the presence of several chemical skin permeation enhancers have revealed that, when such enhancers induce significant skin permeability coefficient enhancement, it is accompanied by significant enhancement in the equilibrium uptake (partitioning) of the permeant into the intercellular lipid component of the stratum corneum (SC). Particularly, it was found that the 1-alkyl-2-pyrrolidones and the 1-alkyl-2-azacycloheptanones, at aqueous solution concentrations that gave skin permeation enhancement (E) of 10 for corticosterone (CS, the permeant), enhanced the equilibrium uptake of beta-estradiol (E2beta, a surrogate permeant) from the aqueous phase into the intercellular lipids of HMS SC by a factor of 5-7. This finding raised the question of whether this uptake enhancement induced by the permeation enhancer under equilibrium conditions would be essentially the same as that determined kinetically from time-dependent permeation experiments utilizing appropriate SC membrane models and Fick's laws of diffusion to treat the data. HMS transport experiments were conducted with CS as the permeant and 1-octyl-2-pyrrolidone (OP) and 1-hexyl-2-azacyloheptanone (HAZ) as the enhancers. In treating the experimental data, a one-layer skin transport model (SC only) and a two-layer model (SC layer and the epidermis/dermis layer) were both investigated. Both the partition coefficient enhancement (E(K)) and the diffusion coefficient enhancement (E(D)) were deduced from the data treatment. The results showed that when the total transport enhancement of CS was around 11, E(K) was in the range of 6-8 and E(D) was in the range of 1.5-1.9 using both the one-layer and the two-layer models. This E(K) value was found to be in good agreement with the E2beta partition enhancement obtained directly under equilibrium conditions in previous studies. This indicates that (a) the rate-limiting domain for the transport of the lipophilic permeants across HMS and the HMS SC intercellular lipid domain probed in the equilibrium partitioning experiments are essentially the same, and (b) the total flux enhancement (E) of lipophilic permeants across HMS was driven mainly by enhancing the partitioning of the permeant into the rate-limiting domain (E(K)) and secondarily by enhancing the diffusion coefficients (E(D)) of the permeant in the domain. Comparison of the one-layer and two-layer skin model results revealed that non-steady-state transport of lipophilic compounds across HMS was better described by the two-layer model because the dermis/viable epidermis played a significant role in lipophilic permeant binding.

Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance-Fourier transform infrared spectroscopy

We investigated the effects of 10 phospholipids on the in vitro percutaneous penetration of prednisolone (PR) through the dorsal skin of guinea pigs. A marked enhancing effect of PR penetration was observed in the presence of phospholipids that have unsaturated acyl chains. A maximum of 68-fold enhancement was observed compared to that of control. On the contrary, phospholipids that have saturated acyl chains did not significantly increase the amount of PR passing to the receptor side. Attenuated total reflectance-Fourier transform infrared spectroscopy was used to monitor the outer several microns of stratum corneum (SC) surface. It was observed that phospholipids that have unsaturated acyl chains induced higher and broader absorbance shifts in the C-H bond stretching region while phospholipids that have saturated acyl chains induced lower and sharper absorbance shifts in the C-H bond stretching region. A significant parallel between the amount of PR penetrated and the lipid-chain fluidity of the SC was found. These results suggest that phospholipids may influence the percutaneous penetration of PR by changing the lipid-chain fluidity of the SC.

A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists

The in vitro transdermal absorption of five calcium channel antagonists (nifedipine, nitrendipine, nicardipine, felodipine, and nimodipine) was studied using the skin of hairless rats as a membrane. The aim of this study was to determine the penetration parameters [permeability constant (Kp), lag time (T1, and flux (J)] as measures of the intrinsic transdermal permeabilities of these drugs, in order to predict the potential capacity of these drugs to be formulated in a therapeutical transdermal system (TTS). Reliable prediction of Kp values, using K'w (extrapolated capacity factor in 100% water) and P (n-octanol-water partition coefficient) values as independent variables in the parabolic, bilinear, and hyperbolic functions, were assayed. Nicardipine showed a higher mean transdermal penetration (Kp; 4.9 x 10(-3) cm.h-1) value than the other dihydropyridines. Nifedipine showed the shortest mean T1 value (5.1 h). The permeability rate constants of the calcium channel antagonists assayed can be predicted from their n-octanol-water partition coefficients, using the parabolic function (r = 0.984, p less than 0.01). Nicardipine would be the most suitable candidate for formulation in a TTS design.

Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers

Nine azacycloalkanone (5-, 6-, or 7-member ring) derivatives with an alkyl or alkenyl (terpene) chain (10, 15, or 20 carbons) were compared with 1-dodecylazacycloheptan-2-one (azone, 1) for their effects on the percutaneous penetration of 6-mercaptopurine (6-MP) through excised guinea pig skin. Pretreatment of skin with an enhancer markedly increased penetration and skin accumulation of 6-MP. Superior enhancing effects were observed for enhancers having a terpene chain of 10 carbons and an azacyclo ring with one carbonyl group. Enhancers with a C20 tail chain were less effective. Enhancer ring size had little effect on enhancing activity, whereas the increase in the number of carbonyl groups in the ring caused a decrease. Computer fitting of a penetration profile to Fick's diffusion equation gave two parameters corresponding to diffusion and partitioning of 6-MP. The diffusion parameter was little affected by pretreatment with an enhancer, whereas the partition parameter was markedly increased. This suggests that enhancement is determined by the ability to increase the drug partitioning into the skin and to enlarge the drug concentration gradient in the skin barrier. The primary skin irritation was examined with rabbit dorsal skin in vivo. The enhancers with an alkyl chain induced severer primary irritation (erythema and edema) than those with an alkenyl chain. From the balance between enhancing and irritating activities, it is concluded that 1-geranylazacycloheptan-2-one, 1-farnesylazacycloheptan-2-one and 1-farnesylazacyclopentan-2-one are favorable enhancers.

Absorption of materials by or through the living skin

Synopsis The skin comes into contact with a large range of materials either deliberately or inadvertently. It should be possible to predict the exact transport rates of these materials through the skin as a function of the physicochemical properties of the different compounds. With this sort of knowledge it is possible to predict the exact disposition of compounds and use this in the formulation of new products both in the pharmaceutical and cosmetic field. The information will also be useful from the standpoint of skin toxicology and environmental health. In order to be able to predict this complex process it is necessary to split the overall transport into different component parts. This article will identify these components and provide illustrations. The major areas discussed will be barrier function of the skin, the release properties of different topical formulations and how these may be monitored. Novel means of enhancing the penetration of drugs will be discussed and how some additives that are incorporated into formulations will perhaps alter the barrier function of skin. A mathematical model describing skin penetration has been developed and its use in predicting blood levels will be described. This model has been tested both in animal experiments and in limited human studies and its relevance to these situations will be highlighted. Absorption cutanée et transcutanée in vivo.

Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate

Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of drugs applied to skin is discussed. Experimental data are presented for: (a) the flux of diflorasone diacetate through hairless mouse skin, (b) the percutaneous penetration profile of propylene glycol, (c) the effects of vehicle concentrations of polyoxypropylene 15 stearyl ether and propylene glycol on the percutaneous flux of diflorasone diacetate, (d) skin--vehicle partition coefficients of diflorasone diacetate, (e) the solubility profile of diflorasone diacetate as a function of solvent concentration, and (f) the alteration of the skin's resistance to the penetration of diflorasone diacetate due to propylene glycol. Excess solvent in a vehicle caused a decrease in the percutaneous flux of diflorasone diacetate. Formulations containing 0.05 and 0.1% diflorasone diacetate had similar penetration rates when the solvent concentration was optimized for each percentage of diflorasone diacetate.

The diffusion of nandrolone through occluded and non-occluded human skin

Diffusion constants have been measured for nandrolone in human cadaver skin in vitro under conditions which approximate to both the occluded and non-occluded topical therapeutic situation. The results suggest that occlusion affects the diffusion parameters only marginally, if at all, but appears to reduce the ability of the stratum corneum to "irreversibly" bind a fraction of the applied dose. Studies of nandrolone diffusion in freshly excised human epidermis yield similar results to those from measurements on cadaver skin, and it has also been found that epidermal samples excised from non-involved sites of human psoriatic patients behave under these conditions in essentially the same way as normal epidermis.